Edition:
United Kingdom

Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

2.60USD
17 Nov 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.60
Open
$2.60
Day's High
$2.65
Day's Low
$2.55
Volume
22,349
Avg. Vol
21,710
52-wk High
$6.60
52-wk Low
$2.40

Select another date:

Tue, Nov 7 2017

BRIEF-COMPUGEN REPORTS Q3 LOSS PER SHARE $0.19

* ‍AS OF SEPTEMBER 30, 2017, CASH AND CASH RELATED ACCOUNTS TOTALED $38.5 MILLION, COMPARED WITH $61.5 MILLION AS OF DECEMBER 31, 2016​ Source text for Eikon: Further company coverage:

BRIEF-Compugen to initiate manufacturing of COM902

* Compugen Ltd - ‍advancing COM902 into manufacturing in anticipation of filing an investigational new drug (IND) application in 2019​

BRIEF-Compugen appoints Paul Sekhri as new board chairman

* Compugen welcomes paul sekhri as its new chairman of the board

BRIEF-Compugen Q2 loss per share $0.18

* Compugen ltd - ‍names paul sekhri as chairman of board effective october 2, 2017​

BRIEF-Compugen discloses updates to collaborative activities with Bayer in immuno-oncology

* Compugen discloses updates to collaborative activities with bayer in immuno-oncology

BRIEF-Compugen announces issuance of U.S. patent for COM701, its lead immuno-oncology product candidate

* Compugen Ltd - patent is expected to expire no earlier than February 2036 in U.S. for issued claims Source text for Eikon: Further company coverage:

Select another date: